View Older Stories View More Recent Stories

May 2, 2025 11:18AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.6 calls to 1 put into quarter results and outlook

May 2, 2025 05:51AM Hims & Hers Health, Inc. (HIMS) May 9 weekly 36.50 straddle priced into quarter results

Apr 29, 2025 02:57PM Hims & Hers Health, Inc. (HIMS) call put ratio 1.8 calls to 1 put on 406K contracts as share price up 24%

Apr 29, 2025 11:28AM Piper Sandler Reiterates Neutral Rating on Hims and Hers (HIMS), PT $35, 'Still Struggle to Be Constructive'

Apr 29, 2025 11:26AM TD Cowen (which downgraded HIMS yday) Comments on Hims and Hers (HIMS): 'The partnership came as a surprise to us'

Apr 29, 2025 09:39AM Hims and Hers (HIMS) PT Raised to $26 at BofA Securities 'and increasing our target EBITDA multiple from 17x to 20- 21x to reflect a longer runway of GLP-1 sales'

Apr 29, 2025 09:16AM Morgan Stanley Reiterates Equalweight Rating on Hims and Hers (HIMS), PT $40

Apr 29, 2025 08:41AM Hims & Hers shares surge over 40% on Wegovy pact with Novo Nordisk

Apr 29, 2025 08:32AM Citi Reiterates Sell Rating on Hims and Hers (HIMS), 'We think HIMS will not make any margin on dispensing of Wegovy'

Apr 29, 2025 07:59AM Hims & Hers Health, Inc. (HIMS) Short Sellers Pressured as Shares Spike Following Novo Nordisk (NVO) Pact

Apr 29, 2025 07:31AM Hims & Hers Health, Inc. (HIMS) and Novo Nordisk Team Up to Expand Affordable Access to Care

Apr 29, 2025 05:29AM TD Cowen Downgrades Hims and Hers (HIMS) to Hold Citing Lack of NT Catalysts

Apr 28, 2025 09:53AM Hims & Hers Health, Inc. (HIMS) Volatile on Martin Shkreli Interview with HIMS YouTuber

Apr 25, 2025 05:13AM Hims and Hers (HIMS) PT Lowered to $25 at Citi Amid Valuation Destruction During 2025

Apr 21, 2025 04:57PM Hims & Hers Health, Inc. (HIMS) COO to transition into an advisory role

Apr 16, 2025 04:18PM BofA Securities on Hims and Hers (HIMS): 'Growth slows in March, but still meaningful upside in 1Q'

Apr 16, 2025 05:17AM BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS), PT $22

Apr 11, 2025 10:50AM Hims and Hers (HIMS) PT Raised to $25 at Jefferies Amid Remarkable Collapse Since February

Apr 9, 2025 07:33AM Piper Sandler's Beauty & Wellness Teen Survey: 'Don't See a Beauty Slowdown in Teens'

Apr 7, 2025 06:38AM BofA: 'Weekly GLP-1 TRx growth in March is trending slightly ahead of February'

Apr 2, 2025 10:50AM Hims & Hers Health, Inc. (HIMS) call put ratio 2.7 calls to 1 put amid as share price down 3.4%

Apr 2, 2025 04:39AM Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)

Apr 1, 2025 04:08PM Leerink Cautious on Hims and Hers (HIMS): 'we still have yet to see how the LT growth profile of HIMS' weight loss business can look like'

Apr 1, 2025 04:00PM BofA highlights 10 stocks to own for Q2

Apr 1, 2025 02:16PM BofA Cautious on Hims and Hers (HIMS): 'HIMS to offer Lilly’s Zepbound, expect minimal revenue contribution'

Apr 1, 2025 01:31PM Hims & Hers Health (HIMS) expanding access to personalized weight loss care

Apr 1, 2025 01:04PM Hims & Hers Health, Inc. (HIMS) said to sell Lilly's Zepbound

Mar 28, 2025 06:23AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.7 calls to 1 put

Mar 20, 2025 10:30AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.1 calls to 1 put amid wide price movement

Mar 18, 2025 04:00PM BofA sees 'significant upside' to earnings upside for this popular consumer stock

Mar 18, 2025 05:12AM Hims and Hers (HIMS) PT Raised to $22 at BofA Securities, 'execution risk on the top line for a name that has been a beat and raise story since its IPO'

Mar 11, 2025 05:48AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.2 calls to 1 put amid wide price movement

Mar 11, 2025 05:16AM BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS), PT $21

Mar 10, 2025 03:14PM Citi Reiterates Sell Rating on Hims and Hers (HIMS), PT $27, 'highly unlikely that this appeal changes much'

Mar 7, 2025 05:22PM DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

Mar 7, 2025 11:45AM Hims & Hers Health, Inc. (HIMS) Shares Fall Another 3pct to Levels Last Seen Jan 31

Mar 7, 2025 06:00AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.3 calls to 1 put

Mar 6, 2025 02:57PM Hims & Hers Health, Inc. (HIMS) Trading 50pct Below February High, Down 13pct Today as shares bounce off LOD

Mar 6, 2025 12:33PM Hims & Hers Health, Inc. (HIMS) call put ratio 1.8 calls to 1 put as share price down 12.5%

Mar 6, 2025 08:29AM Citi Reiterates Sell Rating on Hims and Hers (HIMS), PT $27, 'Court Delivers Another Blow to Tirzepatide Compounders'

Mar 6, 2025 05:21AM BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS)

Mar 5, 2025 02:54PM BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS), PT $21, 'we do not see upside to 2025 revenue guidance'

Mar 5, 2025 09:41AM Citi Reiterates Sell Rating on Hims and Hers (HIMS), PT $27, 'We view this as Novo taking a direct shot at HIMS'

Feb 26, 2025 05:30AM Hims and Hers (HIMS) PT Raised to $39 at Truist Securities

Feb 26, 2025 05:07AM Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.21 puts on 427K contracts

Feb 25, 2025 04:35PM Hims and Hers (HIMS) PT Raised to $44 at TD Cowen

Feb 25, 2025 07:43AM Hims and Hers (HIMS) PT Raised to $35 at Piper Sandler; 'Wide Range Of Future Outcomes Keeps Us On Sidelines'

Feb 25, 2025 06:29AM Hims and Hers (HIMS) PT Raised to $40 at Leerink Partners

Feb 25, 2025 06:07AM Hims and Hers (HIMS) PT Raised to $61 at Needham

Feb 25, 2025 05:36AM Leerink Partners Reiterates Market Perform Rating on Hims and Hers (HIMS)

View More Recent Stories View Older Stories